This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Chiron Corporation, Novartis Vaccines & Diagnostics, Gmbh. Active years: 2004-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2010
Title: Jia-Hwa Fang: Innovator in Microparticle Technology
Introduction
Jia-Hwa Fang is a notable inventor based in Oakland, CA, who has made significant contributions to the field of microparticle technology. With a total of 2 patents, Fang's work focuses on the development of innovative microparticle compositions that have potential applications in various biomedical fields.
Latest Patents
Fang's latest patents include groundbreaking work on microparticle compositions and methods for their manufacture. These microparticles are designed to incorporate complexes of biologically active macromolecules and detergents. The compositions utilize polymers such as poly(α-hydroxy acid), polyhydroxy butyric acid, polycaprolactone, polyorthoester, and polyanhydride. The microparticles are formed using cationic, anionic, or nonionic detergents, and their surfaces are engineered to adsorb biologically active macromolecules, including nucleic acids, polypeptides, antigens, and adjuvants. Preferred polymers in these compositions are poly(D,L-lactide-co-glycolides), particularly those with a lactide/glycolide molar ratio ranging from 40:60 to 60:40 and a molecular weight between 30,000 Daltons and 70,000 Daltons. The macromolecules targeted in these innovations include bacterial and viral antigens, such as HIV antigens, meningitis B antigens, streptococcus B antigens, and Influenza A hemagglutinin antigens.
Career Highlights
Throughout her career, Jia-Hwa Fang has worked with prominent organizations in the biotechnology sector. Notably, she has been associated with Novartis Vaccines & Diagnostics and Chiron Corporation. Her expertise in microparticle technology has positioned her as a key figure in the development of advanced biomedical solutions.
Collaborations
Fang has collaborated with esteemed colleagues, including Derek T O'Hagan and Maninder S Hora, who have contributed to her research and innovations in the field.
Conclusion
Jia-Hwa Fang's contributions to microparticle technology exemplify her innovative spirit and dedication to advancing biomedical applications. Her patents reflect a commitment to enhancing the efficacy of drug delivery systems and improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile